T/CITS 178-2024 Active Group standards

T/CITS 178-2024 Neuropsychiatric drug treatment medication monitoring project analysis quality objectives Part 1: 19 drugs or metabolites including chlorzepate

Publish Date: 2024-11-27 Implement Date: 2024-11-27 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CITS 178-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Laboratory medicine

Publish Date: 2024-11-27

Implement Date: 2024-11-27

Scope

Scope: This document specifies the analytical quality objectives and applications of therapeutic drug monitoring (TDM) programs for 19 neuropsychiatric drugs or metabolites. This document is applicable to clinical laboratories, interlaboratory quality evaluation institutions, third-party testing institutions, instrument or reagent manufacturers, and other activities related to TDM project internal quality control, external quality evaluation, and method performance confirmation and validation. Main technical content: Foreword Introduction 1 Scope 2 Normative reference documents 3 Terms and definitions 4 Analysis quality requirements setting 4.1 Setting principles 4.2 Setting indicators 5 Indicator applications 5.1 Intra-laboratory quality control 5.2 Interlaboratory quality evaluation 5.3 Performance verification and confirmation References